Interestingly, some cardiac biomarkers (i.e. myoglobin, B-type natriuretic peptide, galectin-3, fibroblast growth factor 23) tended to provide weaker or no discriminative value in patients with previously known CAD. Here, FGF23 is linked to coronary artery disorder.